User contributions
- 21:53, 31 January 2010 (diff | hist) . . (+65) . . Vendor Selection Criteria (→Demonstrate Clinical Functionality (25%))
- 21:15, 31 January 2010 (diff | hist) . . (+70) . . Vendor Selection Criteria (→Demonstrate Clinical Functionality (25%))
- 21:13, 31 January 2010 (diff | hist) . . (+158) . . Vendor Selection Criteria (→Hardware Platform and Technical Requirements (20%))
- 21:05, 31 January 2010 (diff | hist) . . (+8) . . Vendor Selection Criteria (→Hardware Platform and Technical Requirements (20%))
- 20:25, 31 January 2010 (diff | hist) . . (+77) . . Vendor Selection Criteria (→Hardware Platform and Technical Requirements (20%))
- 20:23, 31 January 2010 (diff | hist) . . (+87) . . Vendor Selection Criteria (→Demonstrate Clinical Functionality (25%))